Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Most cancer centers provide paltry resources for meeting NCI’s CCSG mandate to enhance diversity, study shows

Most cancer centers provide paltry resources for meeting NCI’s CCSG mandate to enhance diversity, study shows

June 07, 2024
Vol.50 No.23
By Matthew Bin Han Ong
Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements
Conversation with The Cancer Letter

Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements

June 07, 2024
Vol.50 No.23
By Matthew Bin Han Ong
Richard Simon, NCI’s visionary biostatistician, dies at 80
Obituary

Richard Simon, NCI’s visionary biostatistician, dies at 80

May 24, 2024
Vol.50 No.21
By Paul Goldberg
As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25
Capitol Hill

As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25

May 24, 2024
Vol.50 No.21
By McKenzie Prillaman
NCI: Cancer center communicators are key to the success of the National Cancer Plan

NCI: Cancer center communicators are key to the success of the National Cancer Plan

May 24, 2024
Vol.50 No.21
By Jacquelyn Cobb
Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity
Trials & Tribulations

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

May 10, 2024
Vol.50 No.19
By Sanju Sinha and Eytan Ruppin
In Brief

NCI renews MUSC Hollings support grant with “outstanding” rating

April 19, 2024
Vol.50 No.16
Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials

Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials

April 12, 2024
Vol.50 No.15
By Jacquelyn Cobb
Rathmell: To improve funding outlook, we must reverse distrust in science
NCI

Rathmell: To improve funding outlook, we must reverse distrust in science

April 12, 2024
Vol.50 No.15
By Matthew Bin Han Ong
NCI creates Cancer Equity Leaders group to improve cancer health equity
Health Equity

NCI creates Cancer Equity Leaders group to improve cancer health equity

April 12, 2024
Vol.50 No.15
By Matthew Bin Han Ong

Posts navigation

Previous1…161718…38Next

Trending Stories

  • Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
    PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.”
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
  • Most Favored Nation drug pricing could put China on top
  • Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
  • Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
    A kit for at-home unsupervised self-collection clears FDA finish line

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account